SSTR5 and digestive system neuroendocrine tumor, grade 1/2: Nevertheless, SST5-targeting may provide additive value in the case of SST2 and SST5 coexpression in the same tumor, like gastroenteropancreatic neuroendocrine tumors, pituitary tumors and gastric cancers.